Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.07/sh

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.07), versus ($0.03) reported last year. Revenue for the quarter came in at $8.1 million, versus $9.25 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
• Can global equities keep rising? UBS sees these factors driving upside